Want to create an interactive transcript for this episode?
Podcast: BioCentury This Week
Episode: Ep. 167 - The IRA, T Cell Therapies & The Distillery
Description:  On the latest BioCentury This Week podcast, BioCentury’s editors assess how companies are upending pipeline and business strategies due to the Inflation Reduction Act, along with other takeaways from a survey on the IRA’s implications, conducted by BioCentury with the support of BIO. They also discuss CMS’s memo outlining how it intends to implement the IRA’s price-setting provisions, the T cell therapy landscape and insights from BioCentury’s Distillery. This week’s podcast is sponsored by Jeito Capital. Reach us by sending a text